• Company Profile

Butterfly Medical develops a novel implant for the prostate, for the treatment of enlarged prostate (BPH), one of the most prevalent diseases in aging men.

The Butterfly implant is delivered in minutes, and retracts the lateral lobes of the prostate to restore urine flow.

On-going clinical trials in Israel show good improvement in symptoms and no cases of implant migration, encrustation or inflammation.

The Butterfly device can be used in prostates ranging from 30 to 120 grams with 5 different implant sizes. Delivery can be done with either a rigid or a flexible cystoscope.

The company plans to expand trials in Israel and in the US.

Dover

PROVIDING LEADING-EDGE SOLUTIONS​

Dover Medical & Scientific Equipment Ltd, established in 1974, is a leader in the medical technology market is Israel.

We represent the most advanced technology companies in Israel, standing at the forefront of knowledge in their field. The company offers cutting edge medical solutions, diagnostic equipment and advanced research tools in the field of Life Sciences.

The company comprises three divisions: medical, diagnostic and research. Among its customers are all hospitals in Israel, Clinics, Laboratories, Universities and research institutes.

miR Scientific is a precision molecular bioscience company with a next-generation statistical science platform that creates and delivers scalable breakthrough technologies for the provision of accessible diagnostic, prognostic, monitoring and companion products and services. Its mission for at-risk cancer populations is to eliminate missed diagnoses and unnecessary or premature interventions that can result in a quality-of-life deterioration and can impose exorbitant financial burdens. Founded in 2014 as a commercial spin-out from the State of New York University at Albany’s Cancer Research Center, miR empowers patients and care providers by enabling highly accurate data-centric information to select optimal treatment and monitoring options for the patient. miR engages stakeholders across the disease continuum to adopt patient-focused innovations with measurable and meaningful outcomes. Among other planned products and services, miR has created the Prostate Cancer Sentinel Assay Test™, which has the potential to save thousands of men from suffering the potentially severe side effects of unnecessary prostate cancer treatments. miR will continue to work with key stakeholders on global clinical trials and pursue concurrent regulatory and Laboratory Developed Lab test strategies. miR welcomes international collaborations to advance novel state-of-the-art technologies that will address large cancer populations.

ONCOTEST

For more than two decades, Oncotest has been focusing on identifying innovative approaches to diagnosing malignant diseases and predicting disease progression, according to the unique genetic profile of the patient and the tumor cells, and to precisely and more effectively customize treatment directions.

Questions relating to our health are among the most significant and important questions in our lives, particularly when we are coping with a severe disease. Based on this understanding, the team at Oncotest meticulously selects the optimal, most accurate molecular tests, in conjunction with the world’s leading laboratories, in order to assist making therapeutic decisions based on the most current and reliable information.

Oncotest offers a set of tests to guide treatment according to the biological characteristics at all stages of the disease:

In prostate cancer – a Screening test to assist in the decision on performing a biopsy;

in a newly diagnosed early-stage low risk prostate cancer, tests are used to obtain information for the purposes of ascertaining the degree of risk and for guiding and customizing treatment;

When at issue is a more advanced stage of prostate cancer, it is important for treatment to be guided by tests to customize biological therapy and to monitor the efficacy of that therapy.

In bladder cancer –In the monitoring of non-muscle invasive bladder cancer tests are used for the purposes of ascertaining the degree of risk and for guiding and customizing treatment;

When at issue is a more advanced stage of bladder cancer, it is important for treatment to be guided by tests to customize biological therapy and to monitor the efficacy of that therapy.